Target intelligence / Profile preview

N-ethylmaleimide-sensitive factor attachment protein, gamma pseudogene 1 (NAPGP1)

Target: NAPGP1
Molecular classification: Other (Pseudogene)

Overview

NAPGP1 is a pseudogene annotated in the human genome and is related to the gamma subunit of the N-ethylmaleimide-sensitive factor attachment protein (gamma-SNAP), but it does not encode a functional protein. Pseudogenes are segments of DNA resembling genes but are non-functional, typically due to mutations or truncations that prevent their expression as functional proteins. NAPGP1 therefore does not participate in canonical biological processes, does not serve as a receptor, enzyme, transporter, or other classical drug target, and has no direct therapeutic or diagnostic value.

Other names: NAPGP1gamma-SNAP pseudogene 1

Beyond the preview

Go deeper on N-ethylmaleimide-sensitive factor attachment protein, gamma pseudogene 1 (NAPGP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-ethylmaleimide-sensitive factor attachment protein, gamma pseudogene 1 (NAPGP1).

Explore the full profile